Found 124 matching trials
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children
PHASE2Primary Objective:
To evaluate for each influenza strain the non-inferiori...
Location
Multiple Locations
Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)
PHASE2This study is in support of the annual application for the variation of the...
Location
Multiple Locations
Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea
PHASE4This study is designed to assess the immunogenicity and safety of the 2010-...
Location
Multiple Locations
Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24
N/AThis EPSS will determine the vaccinee reporting rates (RRs) of suspected AD...
Location
Investigational Site Number : 2460001
A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
PHASE2The purpose of this study is to generate data on immunogenicity and safety ...
Location
Multiple Locations
Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)
PHASE3The clinical trial was conducted in Jintan City of Jiangsu Province, China ...
Location
Jiangsu Provincial Center for Disease Prevention and Control
Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand
PHASE4This study will assess the efficacy of a new intradermal formulation of the...
Location
Silom Community Clinic
Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age
PHASE3The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...
Location
CenExel CNS- Site Number : 8400005
A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older
PHASE3Influenza is an acute respiratory disease caused by influenza viruses. Ther...
Location
Guanyun County Center for Disease Control and Prevention
Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults
PHASE2The trial is a Phase II, open-label trial in healthy subjects aged 18 to 60...
Location
Multiple Locations